These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 26865350

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
    Tauber J, Karpecki P, Latkany R, Luchs J, Martel J, Sall K, Raychaudhuri A, Smith V, Semba CP, OPUS-2 Investigators.
    Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
    Matsumoto Y, Ohashi Y, Watanabe H, Tsubota K, Diquafosol Ophthalmic Solution Phase 2 Study Group.
    Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
    [Abstract] [Full Text] [Related]

  • 5. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
    Davitt WF, Bloomenstein M, Christensen M, Martin AE.
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
    [Abstract] [Full Text] [Related]

  • 6. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
    Tauber J, Davitt WF, Bokosky JE, Nichols KK, Yerxa BR, Schaberg AE, LaVange LM, Mills-Wilson MC, Kellerman DJ.
    Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of retinoic acid ophthalmic emulsion in dry eye.
    Selek H, Unlü N, Orhan M, Irkeç M.
    Eur J Ophthalmol; 2000 Nov; 10(2):121-7. PubMed ID: 10887922
    [Abstract] [Full Text] [Related]

  • 8. Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial.
    Sosne G, Dunn SP, Kim C.
    Cornea; 2015 May; 34(5):491-6. PubMed ID: 25826322
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome.
    Sullivan LJ, McCurrach F, Lee S, Taylor HR, Rolando M, Marechal-Courtois C, Creuzot-Garcher C, Easty DL, Karabatsas C, Bingh Hoh M, Faschinger C, Laroche L.
    Ophthalmology; 1997 Sep; 104(9):1402-8. PubMed ID: 9307633
    [Abstract] [Full Text] [Related]

  • 10. A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye.
    Semba CP, Torkildsen GL, Lonsdale JD, McLaurin EB, Geffin JA, Mundorf TK, Kennedy KS, Ousler GW.
    Am J Ophthalmol; 2012 Jun; 153(6):1050-60.e1. PubMed ID: 22330307
    [Abstract] [Full Text] [Related]

  • 11. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial.
    Chen M, Gong L, Sun X, Xie H, Zhang Y, Zou L, Qu J, Li Y, He J.
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):361-6. PubMed ID: 20698799
    [Abstract] [Full Text] [Related]

  • 12. D-beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board.
    Nakamura S, Shibuya M, Nakashima H, Imagawa T, Uehara M, Tsubota K.
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2379-87. PubMed ID: 15980225
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the clinical course of dry eye syndrome.
    Horwath-Winter J, Berghold A, Schmut O, Floegel I, Solhdju V, Bodner E, Schwantzer G, Haller-Schober EM.
    Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170
    [Abstract] [Full Text] [Related]

  • 14. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS, Sung YM, Lee WS, Kim EC.
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [Abstract] [Full Text] [Related]

  • 15. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
    Moscovici BK, Holzchuh R, Sakassegawa-Naves FE, Hoshino-Ruiz DR, Albers MB, Santo RM, Hida RY.
    Cont Lens Anterior Eye; 2015 Oct; 38(5):373-8. PubMed ID: 25956572
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
    Choi JH, Kim JH, Li Z, Oh HJ, Ahn KY, Yoon KC.
    Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
    [Abstract] [Full Text] [Related]

  • 17. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
    Kinoshita S, Awamura S, Oshiden K, Nakamichi N, Suzuki H, Yokoi N, Rebamipide Ophthalmic Suspension Phase II Study Group.
    Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
    [Abstract] [Full Text] [Related]

  • 18. Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome.
    Brzheskiy VV, Efimova EL, Vorontsova TN, Alekseev VN, Gusarevich OG, Shaidurova KN, Ryabtseva AA, Andryukhina OM, Kamenskikh TG, Sumarokova ES, Miljudin ES, Egorov EA, Lebedev OI, Surov AV, Korol AR, Nasinnyk IO, Bezditko PA, Muzhychuk OP, Vygodin VA, Yani EV, Savchenko AY, Karger EM, Fedorkin ON, Mironov AN, Ostapenko V, Popeko NA, Skulachev VP, Skulachev MV.
    Adv Ther; 2015 Dec; 32(12):1263-79. PubMed ID: 26660938
    [Abstract] [Full Text] [Related]

  • 19. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.
    Matsuo T.
    Jpn J Ophthalmol; 2004 Dec; 48(4):321-7. PubMed ID: 15295655
    [Abstract] [Full Text] [Related]

  • 20. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
    Demiryay E, Yaylali V, Cetin EN, Yildirim C.
    Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.